NDC Compounded Drug 70713-200-05 Phenylephrine
Injection, Solution Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Phenylephrine
NDC crossover of Phenylephrine 1 Mg Ml 5 Ml with NDC 70713-200 a human compounded drug with other similar products matching the same substance name (Phenylephrine) and the same administration route (subcutaneous) or dosage form (injection, solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70324-252-01 | 40mg Phenylephrine In 0.9% Sodium Chloride | Phenylephrine | 250 mL in 1 BAG | Injection, Solution | Intravenous | Sterrx Llc |
70324-701-01 | 20mg Phenylephrine In 0.9% Sodium Chloride | Phenylephrine | 250 mL in 1 BAG | Injection, Solution | Intravenous | Sterrx Llc |
70324-901-01 | 50mg Phenylephrine In 0.9% Sodium Chloride | Phenylephrine | 250 mL in 1 BAG | Injection, Solution | Intravenous | Sterrx Llc |
Frequently Asked Questions
What is the NDC number assigned to 50mg Phenylephrine In 0.9% Sodium Chloride?
50mg Phenylephrine In 0.9% Sodium Chloride was assigned by its manufacturer with NDC product code 70713-200. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for 50mg Phenylephrine In 0.9% Sodium Chloride?
The NDC package code 70713-200-05 was assigned to a 5 mL in 1 VIAL, MULTI-DOSE of phenylephrine administered subcutaneous via injection, solution.
Who manufactures this product?
50mg Phenylephrine In 0.9% Sodium Chloride is manufactured by an outsourced facility and labeled by Wells Pharmacy, Inc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by SterRx LLC with NDC product codes 70324-252-01, 70324-701-01 and 70324-901-01.